The global pharmaceutical industry is in an era of greater uncertainty because of looming patent expiries of established drugs having a direct impact on their sales and profitability. Further discovering new drugs in-house is a risky, time consuming and expensive proposition. This has forced...

Exporting has evolved to be one of the fastest growing economic activities in recent times. Increased interest in exporting can be attributed to changing economic conditions across the world viz. growing liberalization, integration and global competition, etc. However, in this highly competitive...

The drug discovery and development are very expensive, risky and time consuming. It requires several years and billions of dollars for developing a drug to the marketplace. Hence, smaller biotech companies seek to out-license or develop their drugs in collaboration with large pharmaceutical...

There are several determinants that could have an effect on in-licensing decisions by a pharmaceutical or biotech firm. This work studies over 200 licensing deals involving big pharma companies in the period (2011 – 2015) and identifies different factors that could play a role in licensing...